INTRODUCTION
China has been leading the world tilapia culture production since 1998. Today, tilapia is one of the best potential species to export for China aquaculture. However, this species is susceptible to Aeromonas infections, especially for tilapia fry under high-density cultural conditions (Austin and Austin, 1999) . In this genus, Aeromonas veronii biovar sobria (A.vbs) is one of the most important pathogen of numerous animal and human diseases. The abuse of antibiotics against Aeromonas results in that water resources have become the depository of antibiotic resistance genes (Hatha et al., 2005) , which not only increases the production costs in pisciculture, but also transfers the resistant genes to bacterial pathogens of animal and human origins (Lee et al., 2001) .
The alarming increase of drug-resistant bacteria and banning of antimicrobial growth promoters world wide make the search for novel means of fighting bacterial infections and promoting animal growth imperative (Van den Bogaard and Stobberingh, 2000) . One of attractive approaches is anti-adhesion strategy because the majority of infectious bacterial diseases are initiated by adhesion of pathogenic organisms to the tissues of the host (Ofek et al., 2003) . Furthermore, the anti-adherence potential of antibiotics in sub-lethal concentrations to bacteria on intestinal epithelia is one of the mechanisms of antibiotic growth promoter and preventing bacterial infection (Shibl, 
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Our purpose in this study was to assess the effect of ABPs of animal origin and hetero-oligosaccharides from plants on tilapia growth, disease resistance and the adhesion of A.vbs strain BJCP-5 to tilapia enteric epithelia, and to clarify the probable mechanisms of the tested agents promoting tilapia growth and resistance to Aeromonas.
MATERIALS AND METHODS

Bacterial strain and preparation of rabbit polyclonal anti-serum
A.vbs strain BJCP-5 was isolated from diseased red tilapia (Oreochromis mossambicus×Oreochromis niloticus hybrid) with motile Aeromonas septicemia in National Beijing Tilapia Seed Farm, and defined based on morphology, physiology, biochemistry and 16 S rDNA sequences (GenBank accession no. AY909606).
Except for the inactivation of the bacteria with 0.5% formaldehyde in PBS (4°C, 72 h), the preparation of rabbit polyclonal anti-serum against the strain BJCP-5 followed the previous description by Alwan et al. (1998) .
Minimum inhibitory concentrations (MIC) of tested substances
The tested agents used in our study are shown in Table   1 . Three tested ABPs with the molecular weights of 8.0 KD, 6.0 KD, and 7.0 KD derived from enteric mucus of chicken, enteric mucous membrane of pig, and racculus rotundus of rabbit respectively, were purified and identified following the methods of Ma et al. (2004) . Konjac glucomannan (KGLM) with an average molecular weight of 2.7 KD derived from the konjac tuber. It is composed of β-(1→4) linked D-glucopyranose and D-mannopyranose as the main chain with branches through β-(1→3)-glucosyl units. Degree of branching is about 8%, the molar ratio of terminal mannosyl units to glucosyl units is 2:1, and the polymerization degree is 15. Cluster bean galactomannan (CBGAM) with an average molecule weight of 1.8 KD is purified from cluster bean. It has a typical monomer structure with the (1→4) linked β-D-mannopiranosyl backbone substituted in various degrees at O-6 with single unit α-D-galactopyranosyl residues in a molar ratio of 1:1.6. Its polymerization degree of CBGAM is 10. The minimum inhibitory concentrations (MICs) of each agent for A.vbs strain BJCP-5 were determined by the broth micro-dilution method of Atkinson (1980) .
Preparation of feed and growth trials
Puhui tilapia diet (Puhui feedstuff Inc., Beijing, China) was used as a basal diet. Each tested agent was added to the basal diet at 100 mg/kg respectively. The diet was prepared by thoroughly mixing the dry basal diet and the tested agent with cold water until a stiff dough resulted. The dough was then passed through a mincer with die and the resulting spaghetti-like strings were dried. The dried diets were broken up and sieved into 4 mm mesh and stored at 4°C. Tilapia were fed 5% of body weight daily. The daily ration was divided into three equal feeding and fed once every four hours. Fish were weighed weekly and the daily ration was adjusted accordingly.
Four hundred and fifty healthy tilapias from the same pond in National Beijing Tilapia Seed Farm with an average weight of 6.77±0.23 g were assigned randomly to one of six groups, with 3 cages/group (25 tilapias/cage). All cages (L100×W50×D40 cm) were placed in a 36 m 3 tank supplied with flow-through water at 0.6 L/min. The daily dissolved oxygen was 5.5±0.7 mg/L and water temperature was 27±1°C. A control group was fed with the basal diet without tested agents supplement; the other test groups were fed with the basal diet with different tested agents supplement, respectively. On the 21st day of feeding trial, the growth was monitored by collectively weighing each group of fish. Weight gain (%) and feed conversion ratio (FCR) were determined for each group using the following equations: weight gain (%) = [(final weight-initial weight)/initial weight]×100; FCR = Feed given (dry weight)/Body weight gain (wet weight).
Challenge experiments
BJCP-5 were grown on TSB for 24 h at 30°C and harvested by centrifuging the culture at 4,000 rpm for 20 min at 4°C. The cells were then washed three times in sterile PBS (pH 7.4) and final concentration was adjusted to 10 8 CFU/ml. Three challenged methods, namely intraperitoneal injection, immersion, and oral administration, were used to determine the disease resistance of tilapia to BJCP-5.
After the feeding trial, all fish were survived. Seventyfive fish of each group were assigned randomly to four subgroups: 20 fish for intraperitoneal injection, 20 fish for immersion, 25 fish for oral administration, and 10 fish for non-challenge. Each fish for intraperitoneal injection was injected with 0.1 ml (10 7 CFU/ml) of the BJCP-5 suspension. The fish for immersion were immersed into the BJCP-5 suspension with the concentration of 10 8 CFU/ml for 2 h. The fish for oral administration were fed with the former diet in feeding trial supplemented additionally BJCP-5 at 10 5 CFU/g for three days. After the challenge, the challenged subgroups were transferred to separate tank with the same density and water quality as the unchallenged subgroups. During the challenged trial, all fish of each group were fed with the same diet as that in feeding trial.
The mortality was observed for 14 days. Tissues were removed from the freshly dead fish for bacteriological culture to confirm A.vbs strain BJCP-5 as the cause of death. The relative percent survival (RPS) in different treatment groups were calculated by the following formula: relative percent survival (%) = 100-[(test mortality/control mortality)×100].
In vivo anti-adhesion assays
After 3 days of challenge, five fish per subgroup taken A.vbs strain BJCP-5 orally at 10 5 CFU/g diet were anaesthetized with 2-phenoxyethanol and dissected. The anterior intestines were removed and washed six times with cold PBS containing 0.05% Tween-20 (PBS-T, pH 7.4), and subsequently cut into pieces, about 0.3 cm×1.0 cm, and fixed in 2% glutaraldehyde in PBS overnight at 4°C. After washing with PBS buffer, the specimens were postfixed with 2% osmium tetroxide for 90 min. After three washings with PBS, the specimens were dehydrated in a graded series of ethanol to 100%, then were critical point dried using liquid carbon dioxide, and coated with gold. The resulting sections were examined with a HITACH S-570 scanning electron microscope (SEM) . To analyze the bacterial adherence on foregut by SEM quantitatively, the numbers of adhered bacteria of each different visual field (6,000×) were calculated. Results of adherence of BJCP-5 to foregut were expressed in the average values of ten different visual fields per 400 µm 2 .
Culture conditions of bacteria for hydrophobicity and adherence assays
Tryptic soy broth (TSB), prepared according to the manufacturer's instructions, was chosen for the basal medium of bacterial growth. BJCP-5, stored in TSB with 50% sterile glycerol at -20°C, was sub-cultured in TSB at 30°C for 16 h, and diluted to 10 6 CFU/ml with sterile PBS.
One hundred microlitre of the cell suspension was transferred to 20 ml of fresh TSB with or without various concentrations of agents (Table 2) , and incubated for 16 h at 30°C with shaking at 150 rpm.
Bacterial hydrophobicity analysis
The ability of the organisms to adhere to hydrocarbons as a measure of their hydrophobicity was determined according to the method of Pérez et al. (1998) . Cultures of BJCP-5 were harvested in the exponential phase by centrifugation at 12,000 rpm for 5 min at 4°C, washed twice in PBS and finally resuspended in the same buffer. The cell suspension was adjusted to an A 560nm value of approximately 1.0 with the buffer and 2 ml of the bacterial suspensions were put in contact with 0.4 ml of xylene and 
In vitro adherence assays
Preparation of bacteria for adherence assays: The cells were harvested from cultures at the exponential phase of growth by centrifugation (4,000 rpm at 4°C for 30 min), washed twice with PBS and resuspended in PBS (pH 7.4) containing 1 mM MgCl 2 at a density of 10 9 cells/ml, and used immediately for the adhesion assays.
Preparation of tilapia enteric epithelia: The following technique was modified from previous descriptions (Alwan et al., 1998) . Healthy young tilapia (approximate 50 g) raised in 24-26°C from National Beijing Tilapia Seed Farm were anaesthetized with 2-phenoxyethanol. Fish were dissected, and the anterior intestines were removed and transferred into chilled PBS (pH 7.4) kept on ice. The tissue were washed six times with cold PBS containing 0.05% Tween-20 (PBS-T, pH 7.4), then scoured with cold PBS containing penicillin (200 IU/ml) and streptomycin (200 µg/ml). Tissue preparations were dipped in 0.1% sodium hypochlorite for 3 min. After four times washing with sterile cold PBS, tissue preparations were incubated for 1 min in 70% ethanol, and finally tissues were washed three times with sterile glacial PBS.
The tissue preparations were cut into pieces of approximate 0.1 mm×0.1 mm, after washing twice with cold PBS, and then incubated in PBS containing 10 mM EDTA for 20 min at 25°C with shaking at 50 rpm. After incubation, sections were washed four times with PBS to remove the EDTA. Epithelia were dislodged by rubbing the intestinal samples with a sterile syringe plunger. The suspension enriched with epithelia was drained into another tube and washed twice in PBS. The released cells were isolated by filtering the suspension through a 75-µm cell mesh. Cell pellets were collected following a 10 min centrifugation at 1,500 rpm, washed twice and resuspended in PBS.
Coating of microtitre plates with epithelia : The following process was modified from Alwan et al. (1998) . Microtitre plates (96-well) (BIOFIL, Canada JET Biochemical Int., Inc.) were coated with 100 µl of 1 M lysine solution and incubated at 25°C for 30 min. The plates were washed three times with distilled water, and 100 µl of a 1.25% glutaraldehyde solution was immediately added, and incubated at 25°C for 5 min, and then washed twice with distilled water. Epithelia (in PBS) were added to each well. Inverted microscopy was used to determine the optimum number of cells for full coverage of each well, and aliquots varying from 10 3 -10
7 cells/well were tested. Epithelium suspensions of 10 5 cells fully coated each well.
The plates were dried overnight incubation at 30°C, sealed with cling film and stored at room temperature for up to three days. Epithelia bound to microtitre wells were fixed by incubation with 0.25% glutaraldehyde for 10 min. Wells were then washed three times with PBS-T. Non-specific binding of bacteria to the plastic of microtitre wells was blocked by incubation of the plates with 100 µl PBS containing 0.5% (w/v) bovine serum albumin (BSA) for 1 h at 25°C. Wells were then washed three times with PBS-T.
Experimental design and quantitative analysis of adherence using ELISA : To determine the effect of each tested substance on adhesive course, we conducted three experiments shown in Table 2 . In experiment I, BJCP-5 was pre-incubated in TSB with the tested agents, and the in vitro adhesive assay without the tested agents was done. In experiment II, BJCP-5 was pre-incubated in TSB without the tested agents, and the in vitro adhesive assay with the tested agents was performed. The experiment III mimicked in vivo adhesion, both pre-incubation of BJCP-5 and then in vitro adhesive assay were performed with the tested agents supplemented. There are four groups in each experiment, namely high dose group (H), middle dose group (M), low dose group (L), and control group (C) in which the tested agents were not used both in pre-incubation of BJCP-5 and in vitro adhesive assay.
According to the experimental design shown in Table 2 , One hundred microlitre of washed bacterial suspensions (10 9 cells/ml) and/or corresponding agents were added in quadruplet to wells coated with epithelia. The plates were incubated at 30°C for 1.5 h. The adherent bacteria were fixed by overnight incubation with 0.3% formaldehyde in PBS following three times washes with PBS-T. Rabbit antisera against BJCP-5 (100 µl) diluted at 1/500 in PBS with 1% BSA, was added to each well, and incubated for 1 h at 37°C following three times washes with PBS-T. Horseradish peroxidase conjugated goat-anti-rabbit IgG (100 µl) diluted at 1/1,000 in PBS with 1% BSAwas added to each well and reacted for 1 h at 37°C. After a final wash, 100 µl of ortho-phenylenediamine substrate was added to each well and the plates were incubated for an additional 15 min at 30°C in the dark. The enzyme reaction was stopped by the addition of 50 µl of 2 M H 2 SO 4 . ELISA optical density (OD) at 492 nm was determined using a microtitre plate reader (MULTISKAN MK3, Thermo Electron Corporation). Adhesion of BJCP-5 to tilapia epithelia was expressed in OD units.
The pre-immune rabbit sera were used for negative controls. Wells without epithelia were coated with bacteria only (in carbonate/bicarbonate buffer, pH 9.6) to determine the reactivity of the immunized sera and to be used as a positive control. Background values for the ELISA, or the amount of non-specific binding of the immunized sera to epithelia were determined by coating wells with epithelia but without bacteria added.
Statistical analyses
All experiments were performed at least in triplicate. Results were expressed as mean ± standard deviation (SD), and the calculations were performed using MINITAB release 10.1 package (Minitab Inc. USA.). The Duncan's Multiple Range Test of the data was analyzed by the ANOVA Procedure from SAS Software Release 8.1(SAS Institute Inc., Cary, NC, USA).
RESULTS
MIC value of the tested substances
MIC values of the two tested oligosaccharides were above 12,500 µg/ml, and they were generally far higher than that of the ABPs with MICs of 625 to 1,250 µg/ml. BJCP-5 had natural resistance to ampicillin with a MIC of 2,000 µg/ml, and the strain was susceptive to kanamycin with a MIC of 15 µg/ml . BJCP-5 was not susceptible to the tested agents.
Growth
The weight gain percent and feed conversion ratio of different experimental groups are shown in Table 1 . Dietary supplementation with the tested agents enhanced the growth and decreased feed conversion ratio significantly (p<0.05).
Disease resistance
No death was observed in the unchallenged subgroups. All mortalities recorded during the trials were due to the challenge infection with BJCP-5, and observed from the third to tenth day post-challenge. The clinical signs observed in fish were hyperaemia on the ventral side of the body, swollen abdomen, reddish vent slightly protruding, opaque eyes and loss of equilibrium; all typical signs associated with A.vbs infection . The RPS of groups supplemented with ABP and oligosaccharide were higher than that of the control group. Furthermore, the RPS of groups supplemented the same tested agent by oral administration was the highest, followed by the immersion challenge, and the lowest was for injection challenge (Table  1) .
Effect of tested substance on in vivo anti-adhesion
The tested agents supplemented to diet can decrease the adhesion of bacteria to tilapia foregut in oral challenge subgroups with BJCP-5. The average numbers of bacteria per visual field of control group were 15.2 which were significantly higher than that of the tested agent supplement groups with 6.8 to 8.4 cells (p<0.05) (Table 1 and Figure 1) . 
Effect of tested substance in bacterial growth media on Bacterial hydrophobicity
The hydrophobicity of BJCP-5 was enhanced gradually with increasing concentrations of ABPs, but only at the highest concentration of 250 µg/ml the hydrophobicity of bacteria was significantly higher than that in control (p<0.05) ( Table 3) . Although the hydrophobicity of BJCP-5 pre-incubated in KGLM and CBGAM with the lowest concentration of 5 µg/ml were significantly higher than that in control respectively (p<0.05), the hydrophobility decreased with the concentration of tested agents increased (Table 4) .
Effect of test substance on bacterial adherence in vitro
In experiment I, the BJCP-5 co-incubated respectively with three ABPs and two oligosaccharides had lower adhesion than that of control. Furthermore, three ABPs showed the reciprocal dose-dependent anti-adherence effect (Experiment I in Table 3 ); KGLM and CBGAM showed the dose-dependent anti-adhesion (Experiment I in Table 4 ).
In the course of the contact between bacteria and epithelia, the influence of tested agents on adhesion was estimated in experiment II. Three ABPs, KGLM and CBGAM inhibited the adherence of BJCP-5 to tilapia enteric epithelia, and the dose-dependent inhibitory effect was observed (Experiment II in Tables 3 and 4) .
The condition of in vivo adherence was mimicked in experiment III. Three ABPs at 25 µg/ml and 2.5 µg/ml inhibited attachment and showed a reciprocal dosedependent inhibitory effect (p<0.05) (Experiment III in Table 3 ). The KGLM and CBGAM showed a dosedependent inhibitory effect (p<0.05) (Experiment III in Table 4 ).
DISCUSSION
Growth promotion and disease resistance of tested agents
ABPs (Ma et al., 2004) and oligosaccharides (Tang et al., 2005) are promising agents to antagonize bacteria and promote animal growth, our results are consistent with those previous studies. In present study, the tested ABPs and oligosaccharides at 100 mg/kg in supplement, which was far lower than the MICs of tested agents to BJCP-5, promoted tilapia growth and resistance to BJCP-5 infection, but did not inhibit the growth of BJCP-5. In addition, the subgroups challenged by oral administration and immersion showed higher RPS than that challenged by injection. These results suggest that the mechanism of growth promotion and disease resistance is not related to interference in intestinal bacterial growth, but may be correlated with interference in the contact between the surfaces of host and bacteria.
Anti-adherence effect of antibacterial peptides and oligosaccharides
Although there is a controversy on the anti-adherence of ABPs, increased evidences show the anti-adhesive property of ABPs. Islam et al. (2001) reported that the downregulated expression of the ABPs LL-37 and human β-defensin-1 might promote bacterial adherence into host epithelium during early in Shigella spp. infections. Lactoferrin with a sub-MIC of 10 mg/ml (0.125 mM) can inhibit the adhesion of enteropathogenic Escherichia coli to HEp2 cells (Ochoa et al., 2003) . A 23-mer derived from fibronectin at concentrations of 4 to 5 µM inhibited the adherence of Candida albicans to 7-mer (KLRIPSV) peptide-coated PEG beads (Klotz, 2004) . Recently, Guerra et al. (2005) observed that nisin, an ABP produced by lactobacillus, reduced the attachment of Listeria monocytogenes strains.
There are many reports on anti-adherence of glucan (Mata et al., 1997) , mannan (Ofek et al., 2003) , fructooligosaccharides (Bornet et al., 2002) , galactan (Sharon, 2006) , and chitosan (Sano et al., 2001 ). However, it has been rarely reported that KGLM and CBGAM inhibited adhesion of bacteria, especially on relationship of antiadhesion and growth promotion.
Results of adhesion assays in vivo and in vitro in our study indicated that the tested ABPs and oligosaccharides had anti-adhesive effects. Antibiotics at concentrations lower than MICs can inhibit adherence of bacteria in alimentary canal, which is one of the mechanisms of antibiotic promoting animal growth and preventing bacterial infection (Shibl, 1985; Schifferli and Beachey, 1988) . Therefore, anti-adhesion of the tested agents may be one of the mechanisms of growth promotion and disease resistance for tilapia.
Mechanism of anti-adhesion of antibacterial peptides and botanic oligosaccharides
The bacterial adhesion is a complex biological process involving many physicochemical forces, which primarily include hydrophobic interactions, cation bridging and receptor-ligand binding. The surface components responsible for the hydrophobic interactions include hydrocarbons, aromatic amino acids, fatty acids and mycolic acids. The adhesion and hydrophobicity of interface has the positive correlation when other physicochemical forces are same (Mack and Sherman, 1999; Doyle, 2000) . The mutual repulsion between the surfaces of bacteria and host cells with net negative charge can be counteracted by divalent metal ions, which thereby act as a cation bridge between the two surfaces. The receptor on the surface of host cell can 'recognize' the ligand on the bacteria surface with a complementary structure and form a strong (but non-covalent) bond. The change of three physicochemical forces mentioned above, will influence the adherence between bacteria and host cells (Wilson et al., 2002) .
Intestinal ABPs are amphiphilic peptides with a net positive charge and a substantial portion of hydrophobic residues (Selsted et al., 1992; Hancock and Lehrer, 1998) . Therefore, the ABPs can influence the net negative charge of surface of bacteria and host cell. Three tested intestinal ABPs decreased the adhesion of the pro-incubated BJCP-5, but they enhanced the hydrophobicity of bacteria. Moreover, intestinal ABPs interfered with the adherence between BJCP-5 and epithelia through cation bridging and/or receptor-ligand binding, because the adhesion enhanced with the increased concentration of intestinal ABPs in experiment II. It suggests that the adhesive inhibition of the ABPs correlate with cation bridging and/or receptor-ligand binding, but not with hydrophobicity. However, the mechanisms of reciprocal dose-depended inhibition need further investigation.
That KGLM and CBGAM influenced the adhesive characteristic of BJCP-5 through altering the hydrophobicity of cell surface, and impacted on the adhesive process of BJCP-5 with tilapia intestinal epithelia through interfering receptor-ligand binding has been previously reported in other oligosaccharides (Ofek et al., 2003; Sharon, 2006) .
